Up for grabs are nearly 1,100 technologies developed at the labs. Most were developed for use in the biotech, supply chain, manufacturing and cybersecurity sectors. The free licenses are nonexclusive, meaning more than one entity may use each patent.
The move could save entrepreneurs thousands in initial costs. Nonexclusive…
Source: The Business Journal